The Net Margin of Clinuvel Pharmaceuticals Ltd (CUV.AX) is 38.07%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-06-30 | 38.07% |
| 2024-06-30 | 37.31% |
| 2023-06-30 | 37.22% |
| 2022-06-30 | 31.55% |
| 2021-06-30 | 51.18% |
| 2020-06-30 | 45.43% |
| 2019-06-30 | 57.36% |
| 2018-06-30 | 51.36% |
| 2017-06-30 | 42.17% |
| 2016-06-30 | -44.41% |